KIORA PHARMACEUTICALS INC (KPRX)
About KIORA PHARMACEUTICALS INC
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$10.8M
- Total assets
- $24.3M
- Market cap
- $11.1M
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $12.8M
- Operating income
- -$12.8M
- Income tax
- -$1.3M
- Net income
- -$10.8M
- EPS (basic)
- $-2.60
- EPS (diluted)
- $-2.64
Balance sheet
- Total assets
- $24.3M
- Current assets
- $21.7M
- Total liabilities
- $8.1M
- Current liabilities
- $3.6M
- Shareholders’ equity
- $16.1M
Cash flow
- Operating cash flow
- -$10.0M
- Investing cash flow
- $14.4M
- Financing cash flow
- $265.7K
- Net cash flow
- $4.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $11.1M
- EPS (diluted)
- $-2.64
- Shares outstanding
- 4.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 13, 2015
Kiora Pharmaceuticals Inc (KPRX) Stock Price
- Reported a net loss of $10.8M in FY2025.
- Trading 20% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review KIORA PHARMACEUTICALS INC.
Write a review
News about KIORA PHARMACEUTICALS INC
News & sentiment via Polygon.io
Kiora Pharmaceuticals Inc: frequently asked questions
Is Kiora Pharmaceuticals Inc an American company?
Kiora Pharmaceuticals Inc is a US-based company headquartered in Encinitas, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Kiora Pharmaceuticals Inc headquartered?
Kiora Pharmaceuticals Inc is headquartered in Encinitas, California, United States.
Is Kiora Pharmaceuticals Inc publicly traded?
Yes — Kiora Pharmaceuticals Inc is a publicly traded company. Its stock trades under the ticker symbol KPRX on the NASDAQ.
What does Kiora Pharmaceuticals Inc do?
Kiora Pharmaceuticals Inc is an American Pharmaceuticals company in the Health & Beauty sector.
